Articles Tagged With: papillomavirus
-
Provider Training May Boost Rates of HPV Vaccination
Results of a recent study indicate a training intervention to aid provider communication about HPV vaccines with teen patients and their parents increased initiation and completion of the vaccine series.
-
Cervical Cancer Screening May Be Less Effective in Obese Women
Results from a large retrospective study of women undergoing cervical cancer screening indicate that overweight and obese women had an increased risk of cervical cancer compared to normal weight women.
-
Research Update: Human Papillomavirus Vaccine Safe for Adult Women
In a study of more than 3 million adult women in Denmark and Sweden, results indicate that human papillomavirus (HPV) vaccination was not connected with 44 serious chronic diseases.
-
New Study Points to Long-term Effectiveness of 9-Valent HPV Vaccine
Vaccine could prevent 90% of cervical cancer cases worldwide.
-
Task Force Issues Cervical Cancer Screening Guidance: What Changes Can Clinicians Expect?
Ages 30-65: Cervical cytology every three years or HPV testing every five years.
-
Genital HPV in Men: How Common Is It?
In this U.S. cross-sectional survey, the prevalence of genital human papillomavirus (HPV) infection in adult men was 45%, of which 25% were high-risk subtypes. The overall rate of HPV vaccination among those who were eligible was 11%.
-
Genital HPV in Men: How Common Is It?
In this U.S. cross-sectional survey, the prevalence of genital human papillomavirus (HPV) infection in adult men was 45%, of which 25% were high-risk subtypes. The overall rate of HPV vaccination among those who were eligible was 11%.
-
Can the Human Papillomavirus Vaccine Cure Cervical Dysplasia?
In this randomized, controlled trial, the HPV 16/18 vaccine did not hasten resolution of existing oncogenic HPV infections nor prevent persistent HPV 16/18 associated infection and cervical dysplasia recurrence after loop electrosurgical excisional procedure treatment.
-
CDC Recommends Simpler HPV Vaccine Series for Young Adolescents
The CDC has changed its recommendation for the human papillomavirus vaccine administration from a routine three-dose series to a two-dose series for 9- to 14-year-old children.
-
HPV Vaccines: Why Are We Failing to Vaccinate so Many of Our Adolescents?
Barriers to HPV vaccination are multiple.